We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Adds to Migraine Drug Advice With Guidance Covering Preventive Treatments
FDA Adds to Migraine Drug Advice With Guidance Covering Preventive Treatments
Expanding on the clinical development of migraine drugs, the FDA has published a new draft guidance on development of drugs to prevent migraine to complement its current guidance on developing drugs to treat migraine.